Targeted Detection of Apoptotic Pathway Activation
Apoptosis is a tightly regulated, programmed cell death process that is essential in development, immune regulation, and the removal of damaged or cancerous cells. Central to this process are executioner caspases, including caspase-3 and caspase-7, which cleave multiple substrates to induce DNA fragmentation, membrane blebbing, and chromatin condensation. Quantifying activation of these enzymes in response to pharmacological agents, genetic modifications, or stress signals is a core requirement for anti-cancer drug screening, RNAi validation, and toxicological profiling. This apoptosis assay service provides highly sensitive, reproducible quantification of caspase-3/7 activity in diverse mammalian cell lines.
Biochemical Principles of Caspase Assay Detection
The caspase-3/7 assay utilizes a synthetic substrate containing the DEVD peptide sequence, which is specifically cleaved by activated caspase-3 or -7. Upon cleavage, the substrate releases a fluorogenic or luminescent signal proportional to the level of enzymatic activity. The readout reflects apoptosis-specific proteolytic activity and enables quantification across a wide dynamic range. This assay distinguishes apoptotic cell death from necrosis or other forms of cell death, providing mechanistic clarity for compound evaluation or gene silencing studies.
Cell Line Compatibility and Screening Capabilities
This service supports a broad panel of human and rodent cell lines derived from solid tumors, hematological malignancies, and normal tissues. Commonly screened lines include HeLa, MCF-7, A549, Jurkat, HepG2, and HT-29, as well as custom-engineered cell models expressing fluorescent caspase reporters. Screening can be performed in single-point or dose-response formats, with additional endpoints such as cell viability, cell cycle analysis, and morphological assessment used to complement caspase activity data.
Applications in Drug Discovery and Functional Genomics
Caspase-3/7 assays are instrumental in evaluating pro-apoptotic drug candidates, including DNA-damaging agents, kinase inhibitors, and immunotherapies. In RNA interference workflows, these assays confirm whether gene knockdown induces apoptosis through intrinsic or extrinsic pathways. Functional genomics applications include synthetic lethality screens, off-target toxicity evaluation, and identification of resistance-associated pathways. The assay is also used in combination with mitochondrial membrane potential measurements or Annexin V staining to build comprehensive apoptosis profiles.
Data Normalization, Validation, and Scalability
Assay results are normalized to total cell number or parallel viability measurements to correct for compound toxicity or growth inhibition. Positive controls such as staurosporine or camptothecin are included to confirm assay responsiveness. Assays are optimized for 96-well and 384-well microplate formats, enabling high-throughput screening with low reagent volumes and high data reproducibility. Raw signal intensities are converted into fold-change, percent activation, and EC50 values using robust statistical methods and curve fitting algorithms.
Altogen Labs Apoptosis Screening Services
Altogen Labs provides apoptosis assay services focused on caspase-3/7 activation, integrating cell line screening, assay optimization, and downstream data analysis. Their capabilities support small molecule drug discovery, gene function analysis, and preclinical safety assessment. With customized protocols, cell line flexibility, and multi-parametric data acquisition, this service delivers high-content information to support therapeutic development and toxicological decision-making.